1609 Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2015-09, Vol.51, p.S241-S241
Main Authors: Pinter, T, Morrow, P.K, Cesas, A, Croitoru, A, Decaestecker, J, Gibbs, P, Hotko, Y, Jassem, J, Kurteva, G, Novotny, J, O'Reilly, S, Salek, T, Khosrowshahi, L, Reiner, M, Klippel, Z, Blanke, C
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)30697-9